Glen Harbor Capital Management’s Biogen BIIB Stock Holding History

Glen Harbor Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$14.5M	Sell	62,104 -10,612	-15%	-$2.47M	0.3%	71
2019 Q2	$17M	Sell	72,716 -22,176	-23%	-$5.12M	0.36%	62
2019 Q1	$22.4M	Buy	94,892 +21,112	+29%	+$6.65M	0.48%	48
2018 Q4	$22.2M	Sell	73,780 -5,292	-7%	-$1.69M	0.54%	42
2018 Q3	$27.9M	Sell	79,072 -5,040	-6%	-$1.74M	0.56%	42
2018 Q2	$24.4M	Buy	84,112 +10,304	+14%	+$2.9M	0.52%	45
2018 Q1	$20.2M	Buy	73,808 +35,616	+93%	+$11.1M	0.46%	54
2017 Q4	$12.2M	Buy	38,192 +14,280	+60%	+$4.58M	0.28%	83
2017 Q3	$7.49M	Buy	23,912 +4,676	+24%	+$1.38M	0.18%	112
2017 Q2	$5.22M	Buy	19,236 +9,492	+97%	+$2.51M	0.13%	160
2017 Q1	$2.66M	Buy	9,744 +6,608	+211%	+$1.87M	0.07%	250
2016 Q4	$889K	Buy	+3,136	New	+$930K	0.02%	387

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glen Harbor Capital Management's BIIB Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Biogen (BIIB) stake by 15% in Q3 2019, selling an estimated $2.47M and leaving 62,104 shares worth $14.5M. The position accounts for 0.3% of the portfolio, ranked #71.

Glen Harbor Capital Management first reported a position in BIIB in Q4 2016 and has held it in 12 quarters since. The position peaked at $27.9M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Glen Harbor Capital Management held 62,104 shares of Biogen worth $14.5M as of Q3 2019.
Glen Harbor Capital Management sold 10,612 Biogen shares in Q3 2019, an estimated $2.47M.
Biogen made up 0.3% of Glen Harbor Capital Management's portfolio in Q3 2019, its #71 holding.
Glen Harbor Capital Management first reported a position in Biogen in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Biogen position peaked at $27.9M in Q3 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.